Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Frankenman International Ltd Secures FDA Clearance For Its Entire CHEX Range Of Surgical Staplers
Frankenman International Ltd, the manufacturer and supplier of surgical instruments, announced that its entire CHEX™ range of surgical staplers had been granted FDA approval. This development complements the CE and ISO accreditation it has already acquired. FDA approval endorses Frankenman"s commitment to total quality in surgical stapling and wound closure devices, and further validates its position as a trusted alternative supplier in these markets.

Bacterial 'Sex' Causes Antibiotic Resistance
Some disease-causing bacteria are becoming resistant to antibiotics because they have peculiar sex lives, say researchers publishing new results in the journal Science. The new study helps scientists understand how bacteria develop resistance to antibiotics, which is a major challenge for those treating infectious diseases, say the authors from Imperial College London.
News of the day
Interferon Alpha Can Delay Full Onset Of Type I Diabetes: UT Researcher
A low dose of oral interferon alpha shows promise in preserving beta cell function for patients with newly diagnosed type 1 diabetes, or juvenile diabetes, according to researchers at The University of Texas Medical School at Houston.
Oncology

Zimbabwean PM To Meet With Clinton, Obama In Appeal For Foreign Aid

Zimbabwean Prime Minister Morgan Tsvangirai met with U.S. lawmakers in Washington, D.C., Wednesday in an attempt to secure donations for a country in economic collapse, ZimOnline reports. Tsvangirai"s visit is part of "a three-week trip to America and Europe to try to drum up financial support for the power-sharing government," entered into with his political rival, President Robert Mugabe in February, according to ZimOnline (ZimOnline, 6/11). Tsvangirai will meet with Secretary of State Hillary Rodham Clinton on Thursday before meeting President Barack Obama on Friday, VOA News reports (Zulu/Chiripasi, VOA News, 6/10). SAPA/News24 writes, "Obama and Tsvangirai will "discuss the difficult road ahead in Zimbabwe, including how the United States can support the forces of reform as they work to bring the rule of law, respect for human rights, and free and fair elections back to Zimbabwe," the White House said" (SAPA/News24.com, 6/9). "It will be important for the U.S. to give transitional support to us, because the alternative" - such as an increase in hyperinflation, poverty and violence - "is too ghastly if we fail," Tsvangirai said (Magee, Dow Jones Newswires/Wall Street Journal, 6/10). Zimbabwe"s economic crisis has led to a breakdown of basic social services in the country, complicated by a cholera crisis that has infected about 100,000 people and killed more than 4,200. In early June, the U.N. increased its appeal for foreign aid from $550 million to $718 million to meet Zimbabwe"s growing humanitarian crisis (Kaiser Daily Global Health Policy Report, 6/2). However, U.S. leaders are hesitant, Reuters reports. "The top U.S. diplomat for Africa, Johnnie Carson, said this week that Washington was troubled by the absence of reform in Zimbabwe and had no plans for now to offer major aid or lift sanctions against Mugabe. Western aid is only beginning to trickle in - and all of it is bypassing the government," writes Reuters (Reuters, 6/10). NPR"s All Things Considered examines the task ahead of Tsvangirai in convincing U.S. leaders to "to lift sanctions and put some trust in his power-sharing arrangement" (Kelemen, NPR, 6/10). This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009